FDA building.jpgSupplement Regulations
FDA says ingredient studied as drug—β-NMN—is excluded from supplementsFDA says ingredient studied as drug—β-NMN—is excluded from supplements
FDA’s recently held position is likely to cause disruption to the NMN marketplace and may culminate in a fight—perhaps litigation—between the dietary supplement and drug industries, with the public health agency at the center of the dispute.
Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.